Kazia Therapeutics (KZIA) Invested Capital (2009 - 2025)

Kazia Therapeutics has reported Invested Capital for 14 years, with the latest figure at $39.8 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 2917.55% year-over-year to $39.8 million; the trailing twelve-month figure through Dec 2025 stood at $39.8 million (up 2917.55% YoY), and the FY2025 full-year result was $2.8 million, down 11.87% from the prior year.
• Invested Capital for Q4 2025 stood at $39.8 million, up from $2.8 million in the prior quarter.
• The five-year high for Invested Capital was $39.8 million in Q4 2025, with the low at $1.3 million in Q4 2024.
• Historically, Invested Capital has averaged $13.7 million across 5 years, with a median of $10.4 million in 2022.
• Annual changes were most pronounced in 2024 — Invested Capital sank 85.38% — and 2025, when it soared 2917.55%.
• Kazia Therapeutics' Invested Capital stood at $18.6 million in 2021, then tumbled by 59.02% to $7.6 million in 2022, then climbed by 18.62% to $9.0 million in 2023, then slumped by 85.38% to $1.3 million in 2024, then soared by 2917.55% to $39.8 million in 2025.
• The last three Invested Capital figures came in at $39.8 million (Q4 2025), $2.8 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.